Scaling Innovative Clinical Trial Approaches Challenges Progress And Opportunities

Summary

This hybrid workshop, co-convened by the Duke-Margolis Institute for Health Policy and the U.S. Food and Drug Administration ... To keep pace with the ever-changing drug development landscape, the U.S. Food and Drug Administration (FDA)'s Center for ... In this presentation, Dr. Califf discusses the role and value of to Foresight Longevity Biotechnology Seminar Group:* ... Virtual roundtable on how technology adoption has affected the post-pandemic world and the lessons we learned during the ... Mayo Clinic hepatologist John E. Eaton, M.D., discusses the An introduction and overview of FDA's CID Paired Meeting Program. Daniel Lewi, Founder of the CATS Foundation, and Kathleen Flynn, CEO of the National Tay-Sachs & Allied Diseases Association ... This presentation explored how electronic technologies are revolutionizing Learn how to implement decentralised elements in AI is here to stay, but is our healthcare ready for it? I would overview how we successfully utilized artificial intelligence to ... Recorded live at the 2026 ASGCT Annual Meeting in Boston. This video is a portion of the symposium, "Advancing rare disease ...